SCHEMBL6489476

SCHEMBL6489476

[CH2]c1cc(N(C)C)nc2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.49
OPRD1 P41143 1/20 0.49
NCF1 P14598 1/20 0.48
KDM4E B2RXH2 7/20 0.45
TSHR P16473 5/20 0.45
ALDH1A1 P00352 5/20 0.45
GAA P10253 5/20 0.45
HSD17B10 Q99714 3/20 0.45
HPGD P15428 2/20 0.45
GLA P06280 5/20 0.44
MAPK1 P28482 2/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
NUDT1 P36639 1/20 0.42
PKM P14618 1/20 0.42
KDM1A O60341 2/20 0.42
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6489480 0.79 CYP1A2 (0.60) S1PR1OPRD1NCF1KDM4ETSHR
SCHEMBL6213496 0.78 S1PR1 (0.49) S1PR1OPRD1NCF1KDM4ETSHR
SCHEMBL6586126 0.78 TSHR (0.61) S1PR1OPRD1NCF1KDM4ETSHR
SCHEMBL6457843 0.78 S1PR1 (0.52) S1PR1OPRD1NCF1KDM4ETSHR
SCHEMBL8366862 0.76 KDM4E (0.53) S1PR1OPRD1NCF1KDM4ETSHR
SCHEMBL7760642 0.75 S1PR1 (0.47) S1PR1OPRD1NCF1KDM4ETSHR
SCHEMBL2641557 0.75 CYP1A2 (0.64) NCF1KDM4EALDH1A1HPGDMEN1
SCHEMBL16832665 0.74 KDM4E (0.57) S1PR1OPRD1KDM4ETSHRALDH1A1
SCHEMBL3968023 0.71 MAOA (0.50) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL3152061 0.71 KDM4E (0.40) NCF1KDM4ETSHRALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962938-B2 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-6720329-B2 ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA 2004-04-13 US disclosed
EP-1373199-A4 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-04-07 EP disclosed
EP-1373199-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) Bristol-Myers Squibb Pharma Company (US) 2004-01-02 EP disclosed
WO-2002074738-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL-MYERS SQUIBB COMPANY (US) 2002-09-26 WO disclosed